Merus NV (NASDAQ:MRUS)
| 16.90 Delayed Data As of Jan 23 |  -0.21 / -1.23%Today’s Change | 11.00 Today|||52-Week Range 20.95 | +20.03% Year-to-Date |
Latest MRUS News | Press Releases
No recent news for Merus NV.
Today’s Trading
| Previous close | 17.11 |
| Today’s open | 17.35 |
| Day’s range | 16.61 - 17.35 |
| Volume | 60,547 |
| Average volume (3 months) | 104,883 |
| Market cap | $491.1M |
Data as of 3:59pm ET, 01/23/2020
Growth & Valuation
| Earnings growth (last year) | +70.11% |
| Earnings growth (this year) | -49.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +163.50% |
| P/E ratio | NM |
| Price/Sales | 8.46 |
| Price/Book | 3.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DVAXDynavax Technologies... | -0.03 | -0.52% |
| APTOAptose Biosciences I... | +0.03 | +0.48% |
| VYGRVoyager Therapeutics... | -0.23 | -1.77% |
| ADAPAdaptimmune Therapeu... | +0.03 | +0.75% |
Data as of 4:00pm ET, 01/23/2020
Financials
| Next reporting date | April 24, 2020 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $36.9M |
| Annual profit (last year) | -$28.6M |
| Net profit margin | -77.66% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Utrecht, Utrecht |
Forecasts
